Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study von Junlén, H R, Peterson, S, Kimby, E, Lockmer, S, Lindén, O, Nilsson-Ehle, H, Erlanson, M, Hagberg, H, Rådlund, A, Hagberg, O, Wahlin, B E

Volltext

Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study von Wästerlid, T., Biccler, J.L., Brown, P.N., Bøgsted, M., Enblad, G., Mészáros Jørgensen, J., Christensen, J.H., Wahlin, B.E., Smedby, K.E., El-Galaly, T.C., Jerkeman, M.

Volltext

THE CANNABINOID STUDY – 01: INVESTIGATING THE EFFECTS OF CANNABINOIDS IN INDOLENT LEUKEMIC B‐CELL LYMPHOMA von Melén, C.M., Merrien, M., Wasik, A.M., Sonnevi, K., Junlén, H., Christensson, B., Sander, B., Wahlin, B.E.

Volltext

LONG‐TERM SURVIVAL AND LOSS IN EXPECTANCY OF LIFE IN A POPULATION‐BASED COHORT OF 7114 PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA von Smedby, K.E., Ekberg, S., Andersson, P., Enblad, G., Wahlin, B.E., Hasselblom, S., Jerkeman, M., Eloranta, S.

Volltext

Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia von Tam, C.S, Opat, S, D'Sa, S, Jurczak, W, Lee, H.-P, Cull, G, Owen, R.G, Marlton, P, Wahlin, B.E, García-Sanz, R, McCarthy, H, Mulligan, S, Tedeschi, A, Castillo, J.J, Czyż, J, Fernández De Larrea, C, Belada, D, Libby, E, Matous, J, Motta, M, Siddiqi, T, Tani, M, Trněný, M, Minnema, M.C, Buske, C, Leblond, V, Treon, S.P, Trotman, J, Wu, B, Yu, Y, Shen, Z, Chan, W.Y, Schneider, J, Allewelt, H, Cohen, A, Dimopoulos, M.A

Volltext bestellen